Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"

The drug being tested in this study is called Leuprorelin acetate (Leuplin PRO for Injection Kit 22.5 mg). Leuprorelin acetate is being tested to treat people who have prostate cancer. This study will look at the safety in patients with prostate cancer receiving the drug in the routine clinical setting. The study will enroll approximately 300 patients. • Leuprorelin acetate This multi-center trial will be conducted in Japan.